Where can I find the detailed information on the resolutions?

The detailed resolutions are contained in the attachment referenced in the BSE filing (PDF). The summary posted does not include those specifics.

Corporate Action

4 July 2026 at 05:47 pm IST• 1 min read

Sarda Proteins Ltd Board Meets, Approves Resolutions as per Filing

The board convened on 4 July 2026 at the company’s registered office, held for 2 hours 40 minutes and approved several resolutions whose details are attached to the filing.

—Sarda Proteins Ltd

What Sarda Proteins Ltd announced

On 4 July 2026, the Board of Directors of Sarda Proteins Ltd convened at the company’s registered office. The meeting started at 3:00 p.m. and concluded at 5:40 p.m., lasting a total of 2 hours 40 minutes. During the session, the board considered and approved a series of resolutions, the particulars of which are attached to the filing submitted to BSE.

"The Board has, inter alia, considered and approved as attached."

The filing does not elaborate on the nature of the resolutions—whether they pertain to capital restructuring, dividend declaration, share issuance, or other corporate actions. The attached document, referenced in the filing, is the only source of those specifics.

Details of the Board Meeting

Date: Saturday, 4 July 2026
Time: 3:00 p.m. – 5:40 p.m.
Venue: Registered Office of Sarda Proteins Ltd
Agenda: Review and approval of resolutions (exact content not disclosed in the summary)
Filing Timestamp: 2026‑07‑04T12:17:11Z (BSE)

Key facts at a glance

Detail	Value
Company	Sarda Proteins Ltd
BSE Code / Ticker	519242
Meeting Date	4 July 2026
Meeting Duration	2 hours 40 minutes
Filing Date	4 July 2026 (12:17 UTC)
Resolutions Approved	Refer to attached annexure (not disclosed)
Source	BSE filing (PDF)

Why this matters for investors

The board’s approval of resolutions signals that the company is taking formal steps on matters that require shareholder or regulatory consent. While the filing does not specify the resolutions, such board actions can affect corporate governance, capital structure, or dividend policy. Investors should review the attached annexure once it becomes publicly accessible to understand any potential impact on shareholding, dilution, or cash flows.

Conclusion

Sarda Proteins Ltd’s board met on 4 July 2026 and approved a set of resolutions, the details of which are confined to an attached document not summarized in the filing. The outcome has been formally recorded with BSE. Stakeholders awaiting further information should monitor subsequent disclosures that will elaborate on the nature of the approved resolutions.

Frequently asked questions

What was the purpose of the board meeting held on 4 July 2026?

The board met to consider and approve a series of resolutions; the filing only states that the resolutions were approved and refers to an attached document for details.

When and where did the meeting take place?

The meeting was held on Saturday, 4 July 2026, at the registered office of Sarda Proteins Ltd, starting at 3:00 p.m. and ending at 5:40 p.m.

What specific resolutions were approved?

The filing does not disclose the specific resolutions. It mentions that they are attached to the filing, and investors will need to review that annexure for details.

Will the approved resolutions affect shareholders?

The filing does not indicate the nature of the resolutions, so any effect on shareholders—such as dilution, dividend changes, or rights—cannot be determined from the information provided.

Related stocks

519242Sarda Proteins Ltd

Source filing: view original